Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $14 | $14 | $14 |
| Short-Term Investments | $3 | $2 | $3 | $2 |
| Receivables | $10 | $9 | $9 | $10 |
| Inventory | $7 | $7 | $7 | $7 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $34 | $34 | $34 | $35 |
| Property Plant & Equip (Net) | $24 | $24 | $23 | $22 |
| Goodwill | $11 | $11 | $11 | $11 |
| Intangibles | $20 | $19 | $19 | $18 |
| Long-Term Investments | $0 | $24 | $23 | $26 |
| Tax Assets | $1 | $1 | $1 | $1 |
| Other NC Assets | $29 | $5 | $5 | $3 |
| Total NC Assets | $84 | $84 | $83 | $81 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $119 | $118 | $117 | $115 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $6 | $6 |
| Short-Term Debt | $18 | $18 | $19 | $19 |
| Tax Payable | $0 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $12 | $12 | $13 |
| Total Curr. Liab. | $36 | $36 | $37 | $38 |
| LT Debt | $14 | $14 | $13 | $11 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $3 | $3 | $3 | $3 |
| Other NC Liab. | $4 | $3 | $3 | $3 |
| Total NC Liab. | $22 | $22 | $20 | $19 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $2 |
| Total Liabilities | $59 | $57 | $58 | $56 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | $27 | $27 | $27 | $26 |
| AOCI | $0 | $0 | $0 | $19 |
| Other Equity | $17 | $18 | $18 | -$0 |
| Total Equity | $47 | $48 | $47 | $47 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $13 | $13 | $13 | $12 |
| Total Liab. & Tot. Equity | $119 | $118 | $117 | $115 |
| Net Debt | $19 | $18 | $18 | $16 |